LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 42 filers reported holding LUMOS PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $157,098 | -12.3% | 47,596 | -12.3% | 0.00% | – |
| Q2 2023 | $179,120 | +54.2% | 54,279 | +58.5% | 0.00% | – |
| Q1 2023 | $116,127 | +94312.2% | 34,256 | 0.0% | 0.00% | – |
| Q4 2022 | $123 | -100.0% | 34,256 | +5.4% | 0.00% | – |
| Q3 2022 | $287,000 | +14.8% | 32,502 | 0.0% | 0.00% | – |
| Q2 2022 | $250,000 | -17.5% | 32,502 | +1.3% | 0.00% | – |
| Q1 2022 | $303,000 | +54.6% | 32,073 | +13.1% | 0.00% | – |
| Q4 2021 | $196,000 | -27.1% | 28,348 | -0.0% | 0.00% | – |
| Q3 2021 | $269,000 | +17.0% | 28,356 | +22.3% | 0.00% | – |
| Q2 2021 | $230,000 | -15.1% | 23,192 | 0.0% | 0.00% | – |
| Q1 2021 | $271,000 | -67.3% | 23,192 | 0.0% | 0.00% | – |
| Q4 2020 | $828,000 | +158.8% | 23,192 | 0.0% | 0.00% | – |
| Q3 2020 | $320,000 | -16.2% | 23,192 | 0.0% | 0.00% | – |
| Q2 2020 | $382,000 | +100.0% | 23,192 | +3.0% | 0.00% | – |
| Q1 2020 | $191,000 | – | 22,511 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acuitas Investments, LLC | 153,867 | $507,761 | 0.30% |
| Lion Point Capital, LP | 78,351 | $258,558 | 0.12% |
| Minerva Advisors LLC | 26,549 | $84 | 0.06% |
| Wealth Advisors of Iowa, LLC | 11,699 | $38,606 | 0.03% |
| Marquette Asset Management, LLC | 31,088 | $102,591 | 0.02% |
| Greenwich Wealth Management LLC | 49,002 | $162 | 0.02% |
| Key FInancial Inc | 10,927 | $36,059 | 0.01% |
| Paladin Advisory Group, LLC | 4,387 | $14,477 | 0.01% |
| Blackstone Inc. | 468,145 | $1,544,879 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $157,222 | 0.00% |